Studies of binding modes of (S)-mephenytoin to wild types and mutants of cytochrome P450 2C19 and 2C9 using homology modeling and computational docking
- PMID: 15648259
- DOI: 10.1007/s11095-004-7680-8
Studies of binding modes of (S)-mephenytoin to wild types and mutants of cytochrome P450 2C19 and 2C9 using homology modeling and computational docking
Abstract
Purpose: This study investigated the structural features of CYP2C19 complexed with (S)-mephenytoin, using computational methods. In addition to wild-type CYP2C19 proteins (1A and 1B), which have selective 4-hydroxylase activities of (S)-mephenytoin, CYP2C19 mutants were also studied, together with a wild type and artificial mutants of CYP2C19.
Methods: Three-dimensional structures of wild-type and mutant proteins of CYP2C19 and CYP2C9 were estimated from homology modeling using the crystal structure of rabbit CYP2C5 as a reference. The binding mode of (S)-mephenytoin to CYP2C19 was investigated using computational docking.
Results: The results reproduced the specific bindings between (S)-mephenytoin and the wild types of CYP2C19. Our findings suggest that Asp293 of CYP2C19 plays an important role in the binding of (S)-mephenytoin, which was surrounded by Vall13 and Ala297, and points the phenyl ring at the heme iron. In addition the wild types of CYP2C19, the computational docking studies also accounted for the experimental activities of CYP2C19 mutants, and wild-type and mutant CYP2C19 proteins.
Conclusions: These results confirm that the predicted three-dimensional structure of the CYP2C19-(S)-mephenytoin complex is reasonable, and that this strategy is useful for investigating complex structures. Virtual screening for drug discovery can also be carried out using these methods.
Similar articles
-
Identification of human CYP2C19 residues that confer S-mephenytoin 4'-hydroxylation activity to CYP2C9.Biochemistry. 2001 Feb 20;40(7):1937-44. doi: 10.1021/bi001678u. Biochemistry. 2001. PMID: 11329260
-
Amino acid residues affecting the activities of human cytochrome P450 2C9 and 2C19.Drug Metab Dispos. 2002 Aug;30(8):931-6. doi: 10.1124/dmd.30.8.931. Drug Metab Dispos. 2002. PMID: 12124312
-
Characterization of monkey cytochrome P450, P450 CMLd, responsible for S-mephenytoin 4-hydroxylation in hepatic microsomes of cynomolgus monkeys.Arch Biochem Biophys. 1994 Jun;311(2):395-401. doi: 10.1006/abbi.1994.1254. Arch Biochem Biophys. 1994. PMID: 8203903
-
[The molecular mechanism of polymorphism of S-mephenytoin hydroxylative metabolism].Sheng Li Ke Xue Jin Zhan. 1995 Jan;26(1):23-8. Sheng Li Ke Xue Jin Zhan. 1995. PMID: 7604218 Review. Chinese.
-
Clinical significance of the cytochrome P450 2C19 genetic polymorphism.Clin Pharmacokinet. 2002;41(12):913-58. doi: 10.2165/00003088-200241120-00002. Clin Pharmacokinet. 2002. PMID: 12222994 Review.
Cited by
-
Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets.J Comput Aided Mol Des. 2007 Sep;21(9):539-48. doi: 10.1007/s10822-007-9137-8. Epub 2007 Oct 25. J Comput Aided Mol Des. 2007. PMID: 17960328
-
Molecular Dynamics Simulations to Investigate the Influences of Amino Acid Mutations on Protein Three-Dimensional Structures of Cytochrome P450 2D6.1, 2, 10, 14A, 51, and 62.PLoS One. 2016 Apr 5;11(4):e0152946. doi: 10.1371/journal.pone.0152946. eCollection 2016. PLoS One. 2016. PMID: 27046024 Free PMC article.
-
A computational study of CYP3A4 mediated drug interaction profiles for anti-HIV drugs.J Mol Model. 2011 Aug;17(8):1847-54. doi: 10.1007/s00894-010-0890-6. Epub 2010 Nov 16. J Mol Model. 2011. PMID: 21080015
-
Evaluation of influence of single nucleotide polymorphisms in cytochrome P450 2B6 on substrate recognition using computational docking and molecular dynamics simulation.PLoS One. 2014 May 5;9(5):e96789. doi: 10.1371/journal.pone.0096789. eCollection 2014. PLoS One. 2014. PMID: 24796891 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources